ETF Series Solutions - Loncar China BioPharma ETF

NasdaqGM:CHNA Stock Report

Mkt Cap: US$4.5m

ETF Series Solutions - Loncar China BioPharma ETF Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CHNA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies20.4%
Institutions49699.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 3 shareholders own 0% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0%
Blue Bell Private Wealth Management, LLC
308$5.1k0%no data
0%
Morgan Stanley & Co. International Plc Investment Account
188$3.1k0%no data
0%
Tower Research Capital LLC
2$33.00%no data